Burden of Disease and Risk Factors
暂无分享,去创建一个
Nuno Lunet | N. Lunet | C. E. Santos | Catarina L. Santos | Cledy Eliana dos Santos | N Lunet | C. D. Santos
[1] A. Wolk,et al. Midlife fruit and vegetable consumption and risk of dementia in later life in Swedish twins. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[2] A. Hofman,et al. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[3] L. Fratiglioni,et al. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. , 1991, International journal of epidemiology.
[4] A. de Mendonça,et al. [An estimate of the prevalence of dementia and Alzheimer's disease in Portugal]. , 1994, Acta medica portuguesa.
[5] J. Schmeidler,et al. Diabetes mellitus in midlife and the risk of dementia three decades later , 2004, Neurology.
[6] John Breitner,et al. Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. , 2003, Archives of neurology.
[7] K Yaffe,et al. Midlife cardiovascular risk factors and risk of dementia in late life , 2005, Neurology.
[8] H. Soininen,et al. Incidence and Risk Factors for Mild Cognitive Impairment: A Population-Based Three-Year Follow-Up Study of Cognitively Healthy Elderly Subjects , 2004, Dementia and Geriatric Cognitive Disorders.
[9] A. Hofman,et al. Dietary Intake of Antioxidants and Risk of Alzheimer Disease , 2002 .
[10] A Hofman,et al. Prognosis with stroke in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[11] P. Hof,et al. Clinicopathological validation study of four sets of clinical criteria for vascular dementia. , 2002, The American journal of psychiatry.
[12] C. Mathers,et al. Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.
[13] V. Cruz,et al. Prevalence and pattern of cognitive impairment in rural and urban populations from Northern Portugal , 2010, BMC Neurology.
[14] L. Launer,et al. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.
[15] N. Lunet,et al. Caffeine intake and dementia: systematic review and meta-analysis. , 2010, Journal of Alzheimer's disease : JAD.
[16] B. Winblad,et al. Leisure-time physical activity at midlife and the risk of dementia and Alzheimer's disease , 2005, The Lancet Neurology.
[17] A. Minarini,et al. Alzheimer's disease: new approaches to drug discovery. , 2009, Current opinion in chemical biology.
[18] A. King,et al. The question of familial meningiomas and schwannomas: , 2000, Neurology.
[19] B. Winblad,et al. Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study , 2004, BMJ : British Medical Journal.
[20] A. Hofman,et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.
[21] C. Jack,et al. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. , 2007, Archives of neurology.
[22] W. Jagust,et al. The Role of APOE ∊4 in Modulating Effects of Other Risk Factors for Cognitive Decline in Elderly Persons , 1999 .
[23] Deborah Gustafson,et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study. , 2004, Archives of neurology.
[24] M. Wolfe,et al. Selective amyloid-β lowering agents , 2008, BMC Neuroscience.
[25] Hilkka Soininen,et al. Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. , 2005, Archives of neurology.
[26] Sara Rosenblum,et al. Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment. , 2006, Archives of general psychiatry.
[27] J. Manson,et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.
[28] E. Sigurdsson. Tau-focused immunotherapy for Alzheimer's disease and related tauopathies. , 2009, Current Alzheimer research.
[29] I. Rosenberg,et al. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. , 2007, Archives of internal medicine.
[30] Laura Fratiglioni,et al. The epidemiology of the dementias: an update , 2007, Current opinion in psychiatry.
[31] B. Winblad,et al. Aging and the occurrence of dementia: findings from a population-based cohort with a large sample of nonagenarians. , 1999, Archives of neurology.
[32] B. Winblad,et al. Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. , 2003, Archives of neurology.
[33] M. Ganguli,et al. Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia. , 2009, Current psychiatry reviews.
[34] Ladislav Volicer,et al. The clinical course of advanced dementia. , 2009, The New England journal of medicine.
[35] Piero Antuono,et al. Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors , 2008, The Lancet Neurology.
[36] Ramon Diaz-Arrastia,et al. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. , 2008, JAMA.
[37] L. Fratiglioni,et al. Physical exercise at midlife and risk of dementia three decades later: a population-based study of Swedish twins. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.
[38] D. Bennett,et al. The apolipoprotein E ϵ4 allele and incident Alzheimer’s disease in persons with mild cognitive impairment , 2005 .
[39] B. Winblad,et al. Apolipoprotein E ε4 magnifies lifestyle risks for dementia: a population-based study , 2008, Journal of cellular and molecular medicine.
[40] Sotirios Giannopoulos,et al. Metabolic Syndrome and Alzheimer's Disease: A Link to a Vascular Hypothesis? , 2008, CNS Spectrums.
[41] Janice E Graham,et al. Prevalence and severity of cognitive impairment with and without dementia in an elderly population , 1997, The Lancet.
[42] R. Mayeux,et al. The influence of smoking on the risk of Alzheimer’s disease , 1999, Neurology.
[43] Jean-François Dartigues,et al. Fish, meat, and risk of dementia: cohort study , 2002, BMJ : British Medical Journal.
[44] H. Soininen,et al. Fat Intake at Midlife and Risk of Dementia and Alzheimer’s Disease: A Population-Based Study , 2006, Dementia and Geriatric Cognitive Disorders.
[45] C. Mathers,et al. Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.
[46] R. Petersen. Mild cognitive impairment as a diagnostic entity , 2004, Journal of internal medicine.
[47] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[48] R. Petersen,et al. Association of Low Plasma Aβ42/Aβ40 Ratios With Increased Imminent Risk for Mild Cognitive Impairment and Alzheimer Disease , 2007 .
[49] D. Foley,et al. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. , 2004, American journal of epidemiology.
[50] S. Riedel-Heller,et al. Mild cognitive impairment , 2006, Neurology.
[51] K. Blennow,et al. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study , 2006, The Lancet Neurology.
[52] R. Havlik,et al. Midlife blood pressure and dementia: the Honolulu–Asia aging study☆ , 2000, Neurobiology of Aging.
[53] R S Wilson,et al. Dietary fat intake and 6-year cognitive change in an older biracial community population , 2004, Neurology.
[54] J. Dickens,et al. Prevalence of cognitive impairment , 2001, Neurology.
[55] L. Hansson,et al. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. , 1998, Hypertension.
[56] P. Scheltens,et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria , 2007, The Lancet Neurology.
[57] O. Hanon,et al. Vascular risk factors, cognitve decline, and dementia , 2008, Vascular health and risk management.
[58] M. Kivipelto,et al. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention , 2009, Dialogues in clinical neuroscience.
[59] R. Mayeux,et al. Low-density lipoprotein cholesterol and the risk of dementia with stroke. , 1999, JAMA.
[60] Kaarin J Anstey,et al. Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. , 2007, American journal of epidemiology.
[61] P. Ritz,et al. IANA (International Academy on Nutrition and Aging) Expert Group: weight loss and Alzheimer's disease. , 2007, The journal of nutrition, health & aging.
[62] A Hofman,et al. Diabetes mellitus and the risk of dementia , 1999, Neurology.
[63] JoAnn E. Manson,et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. , 2004 .
[64] K. Anstey,et al. Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[65] M. Kaste,et al. Comparison of Different Clinical Criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the Diagnosis of Vascular Dementia , 2000, Stroke.
[66] K. Ritchie,et al. Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal. , 2010, Journal of Alzheimer's disease : JAD.